Dr Pan speaks with ecancer at EHA 23 about a novel CD22 CAR-T cell for paediatric B-ALL. She outlines the remission rates and safety associated with the treatment. For more on these results, watch her presentation of data at a press session...
Original Article: Novel CD22 CAR-T therapy for paediatric leukaemia